Tag Archives

Ictus e TIA: cure tempestive e appropriate la chiave del successo

Pubblicato il 27 Aprile 2016

In caso di attacco ischemico transitorio o ictus lieve, la valutazione e l’intervento tempestivi in appositi reparti riducono sostanzialmente il rischio di eventi cardiovascolari o di morte nell’anno successivo. Lo studio multicentrico pubblicato sul New England Journal of Medicine si è svolto nell’ambito del TIAregistry.org project. Sono stati arruolati, dal 2009 al 2011, 4789 pazienti […]

Diabete in primo piano

Pubblicato il 18 Giugno 2014

Il Lancet, in concomitanza con il convegno della American Diabetes Association, ha pubblicato una serie di articoli sul diabete. Un’occasione per fare il punto della situazione sui risultati delle ricerche più recenti e sui dati epidemiologici più aggiornati. Diabete e obesità L’editoriale del Lancet (Back to the basics of diabetes), dopo aver evidenziato il preoccupante […]

Accedi agli articoli

Marcus GM et al. Acute consumption of alcohol and discrete atrial fibrillation events. Ann Intern Med 2021 Aug 31. doi: 10.7326/M21-0228. Epub ahead of print. PMID: 34461028.

Fakir AMS et al. Pandemic catch-22: the role of mobility restrictions and institutional inequalities in halting the spread of COVID-19. PLOS ONE 2021; 16(6): e0253348.

Alemany S, Avella-García C, Liew Z, et al. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts. Eur J Epidemiol (2021). https://doi.org/10.1007/s10654-021-00754-4

Salazar de Pablo G et al. Universal and selective interventions to prevent poor mental health outcomes in young people: systematic review and meta-analysis. Harvard Review of Psychiatry 2021;29 (3) 196-215.

Currie JM et al. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the covid-19 pandemic. JAMA Netw Open 2021;4(4):e216147.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1375-1386.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1363-1374.

Zichi C et al. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. Eur j Canc 2021;149:49-60.

Seidler AN et al.; on behalf of the International Liaison Committee On Resuscitation Neonatal Life Support Task Force. Umbilical cord management for newborns <34 weeks' gestation: a meta-analysis. Pediatrics 2021; 147 (3) e20200576.

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.